Pharmaceutical compositions of short-acting sedative...

Details Pharmaceutical compositions of short-acting sedative... Pharmaceutical compositions of short-acting sedative...

2011-07-19

2011-07-19

Padmanabhan, Sreeni (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S816000, C514S538000, C514S217110

Reexamination Certificate

active

07981931

ABSTRACT:
The invention provides pharmaceutical compositions comprising a phenylacetic acid ester compound useful for inducing or maintaining general anesthesia or sedation in mammals, methods for preparing such compositions, and methods for inducing or maintaining anesthesia or sedation using such compositions.

REFERENCES:
patent: 3086978 (1963-04-01), Hiltman et al.
patent: 3484527 (1969-12-01), Arnold et al.
patent: 3510559 (1970-05-01), Arnold et al.
patent: 3511877 (1970-05-01), Arnold et al.
patent: 4401830 (1983-08-01), Umumura et al.
patent: 4415556 (1983-11-01), Bretschneider
patent: 4711902 (1987-12-01), Serno
patent: 4798846 (1989-01-01), Glen et al.
patent: 4918092 (1990-04-01), Frenette et al.
patent: 5092838 (1992-03-01), Faict et al.
patent: 5242944 (1993-09-01), Park et al.
patent: 5714520 (1998-02-01), Jones et al.
patent: 6028108 (2000-02-01), George
patent: 6140373 (2000-10-01), May et al.
patent: 6140374 (2000-10-01), May et al.
patent: 6147122 (2000-11-01), Mirejovsky et al.
patent: 6177477 (2001-01-01), George et al.
patent: 6281175 (2001-08-01), Lyons et al.
patent: 6469069 (2002-10-01), Mirejovsky et al.
patent: 6726919 (2004-04-01), Pace et al.
patent: 6887866 (2005-05-01), Jenkins et al.
patent: 7015346 (2006-03-01), Jenkins et al.
patent: 7514425 (2009-04-01), Jenkins et al.
patent: 2003/0134908 (2003-07-01), Jones et al.
patent: 2003/0153554 (2003-08-01), Jenkins et al.
patent: 1134981 (1962-08-01), None
patent: 2731460 (1978-01-01), None
patent: 1518819 (1999-12-01), None
patent: 0236280 (1987-09-01), None
patent: 906250 (1961-05-01), None
patent: 941694 (1963-11-01), None
patent: 1032872 (1966-06-01), None
patent: 1571395 (1980-07-01), None
patent: 961265 (2008-10-01), None
patent: 60-38343 (1985-02-01), None
patent: 9632135 (1996-10-01), None
patent: 2004037750 (2004-06-01), None
Lee et al., “The Application of NMR Techniques to the Structural Confirmation of O-Substituted 3,4-Dihydroxyphenylacetic Acid Derivatives”, Bull. Korean Chem. Soc, vol. 13, No. 1, pp. 87-91 (1992) and Chemical Abstract XP-002305075 (2 pages).
Strazzolini et al, “Nitrolysis of t-Butyl and 1-Adamantyl Esters” Tetrahedron Letters, vol. 39, pp. 9255-9258 (1998).
Office Action dated Aug. 8, 2008 cited in copending U.S. Appl. No. 11/332,409.
Notice of Allowance dated Oct. 17, 2005 for U.S. Appl. No. 10/980,067.
Office Action dated Jun. 17, 2005 for U.S. Appl. No. 10/980,067.
Notice of Allowance dated Feb. 22, 2005 for U.S. Appl. No. 10/350,624.
Notice of Allowance dated Sep. 20, 2004 for U.S. Appl. No. 10/350,624.
Office Action dated May 28, 2004 for U.S. Appl. No. 10/350,624.
Clarke “The eugenols,” Intravenous Anesthesia, Chapter 8, pp. 162-192 (1974).
MacKenzie et al., “Formulation and evaluation of a propanidid hydroxypropryl-beta-cyclodextrin solution for intravenous anesthesia,” Int Journ of Pharmaceutics (1997) 159:191-196.
Swerdlow “A trial of propanidid (FBA.1420): a new ultrashort-acting anaesthetic,” Brit J Anaesth (1965) 37 (10)785-789.
Wynands et al., “A clinical study of propanidid (FBA 1420),” Can Anaes Soc J (1985) 12(6):587-594.
Zipf et al., “[Local and endoanesthetic side effects of the short acting narcotic propanidide and some analogues. Effect of a solvent agent on the degree of effectiveness],” (1967) 17(8):1021-1028.
Anaesthesia News, No. 194 Sep. 2003, pp. 1-24.
Notice of allowance dated Nov. 25, 2008 received in copending U.S. Appl. No. 11/332,409.
Anesthesiology, Longnecker et al., 2007, McGraw-Hill Professional, pp. 865-866.
Jenkins et al., Abstracts from the Society of Intravenous Anaesthesia (UK)'s Annual Scientific Meeting in Glasgow, May 30-31, 2003, Anaesthesia, 2004 59 pages 100-102.
Klockgether-Radke et al., “Anesthesia with propanidid in a liposomal preparation. An experimental study in swine,” Anaesthesist. (1995) 44(8) abstract in English.
Bobey et al., “Selection of disodium edetate as the optimal antimicrobial additive for use in propofol emulsion,” Antimicrobial Additive (2000) 25(11):589-603.
Physicians' Desk Reference, PDR 56 Edition 2002, p. 667 and pp. 863-864 (2002).
Stevens et al., “Lipid Emulsions as Drug Delivery Systems,” Business Briefing: Pharmatech 2003 pp. 1-4 (2003).
Sublimaze 2ml injection, 10ml injection 4 pages. South Afrianc Electronic Package inserts. Published by Malayde Information Systems, Publication date Apr. 19, 1984, Jan. 21, 1983.
HCAPLUS, Document No. 70:55895; Puetter, Johann (1968).
Office Action dated Apr. 14, 2010 in co pending U.S. Appl. No. 12/400,942.
Final Office Action dated Oct. 12, 2010 received in copending U.S. Appl. No. 12/400,942.
Notice of allowance dated Jan. 4, 2011 received in copending U.S. Appl. No. 12/400,942.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions of short-acting sedative... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions of short-acting sedative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of short-acting sedative... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2637094